|
|
Click
Subscribe
to join the NIH Calendar of Events e-mail list or
Sign In
to add or modify your events.
Event Details
E-mail this page
|
|
|
|
|
|
|
|
|
|
|
Event Type:
|
Lecture (This is an NIH Science event)
|
|
|
|
Title:
|
NCI Support for Cancer Immunology
|
|
|
|
Description:
|
Norman E. “Ned” Sharpless, M.D., was officially sworn in as the 15th director of the National Cancer Institute (NCI) on October 17, 2017. Prior to his appointment, Dr. Sharpless served as the director of the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center, a position he held since January 2014.
Dr. Sharpless was a Morehead Scholar at UNC–Chapel Hill and received his undergraduate degree in mathematics. He went on to pursue his medical degree from the UNC School of Medicine, graduating with honors and distinction in 1993. He then completed his internal medicine residency at the Massachusetts General Hospital and a hematology/oncology fellowship at Dana-Farber/Partners Cancer Care, both of Harvard Medical School in Boston.
After 2 years on the faculty at Harvard Medical School, he joined the faculty of the UNC School of Medicine in the Departments of Medicine and Genetics in 2002. He became the Wellcome Professor of Cancer Research at UNC in 2012.
Dr. Sharpless is a member of the Association of American Physicians as well as the American Society for Clinical Investigation (ASCI), the nation’s oldest honor society for physician–scientists, and served on the ASCI council from 2011 to 2014. Dr. Sharpless was an associate editor of Aging Cell and deputy editor of the Journal of Clinical Investigation. He has authored more than 150 original scientific papers, reviews, and book chapters, and is an inventor on 10 patents. He cofounded two clinical-stage biotechnology companies: G1 Therapeutics and HealthSpan Diagnostics.
In addition to serving as Director of NCI, Dr. Sharpless continues his research in understanding the biology of the aging process that promotes the conversion of normal self-renewing cells into dysfunctional cancer cells. Dr. Sharpless has made seminal contributions to the understanding of the relationship between aging and cancer, and in the preclinical development of novel therapeutics for melanoma, lung cancer, an
|
|
|
|
Series Name:
|
IIG seminar Series
|
|
|
|
Videocast:
|
Event will be videocast LIVE on the Web
|
|
|
|
Videocast URL:
|
http://videocast.nih.gov
|
|
|
Event will be available in the videocast ARCHIVE
|
|
|
|
Special Instructions:
|
To arrange sign language interpretation for an event go to the Office
of Research Services (ORS) Interpreting Service Requests web page.
|
|
|
|
|
|
|
|
|
Date/Time:
|
|
Wednesday, June
20,
2018
4:00pm
-
4:45pm
|
|
|
|
|
|
Click on
(MS Outlook) or
(Mac iCal) or
(MS Entourage for MAC) to add an event into your Calendar. Need Help?
|
|
|
|
|
|
|
Name:
|
Normal E. Sharpless, M.D.
|
|
Title:
|
Director, NCI
|
|
Organization:
|
NCI/NIH
|
|
|
|
|
|
|
|
|
|
|
Organization(s):
|
[NIH] Immunology Interest Group
|
|
|
|
|
|
|
|
|
Location:
|
On the main NIH Campus
|
|
Building:
|
Building 10, Lipsett
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
View by: Day | Week | Month | Year
Calendar Home Page | Feedback | NIH Home Page
|
